SCHEMBL7016134

SCHEMBL7016134

CC(C)(C)OC(=O)N1CCN(Cc2nc3[c]cccc3[nH]2)CC1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.45
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
TBK1 Q9UHD2 6/20 0.42
CCNK O75909 1/20 0.41
CDK12 Q9NYV4 1/20 0.41
VCP P55072 1/20 0.41
ACKR3 P25106 3/20 0.40
VEGFA P15692 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
TERT O14746 1/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31569732 0.76 TBK1 (0.44) TBK1DRD2DRD4
SCHEMBL23964227 0.76 LMNA (0.53) TBK1VEGFAEGLN1DRD4
SCHEMBL29111354 0.74 GAA (0.66) DRD4POLB
SCHEMBL23932558 0.74 RPS6KB1 (0.55) TBK1
SCHEMBL23964249 0.73 HRH4 (0.60) PARP1CHRM2CHRM4CHRM1CHRM3
SCHEMBL465791 0.71 CHRM2 (0.47) PARP1CHRM2CHRM4CHRM1CHRM3
SCHEMBL2862442 0.70 ALDH1A1 (0.60) CHRM2CHRM4CHRM1CHRM3VEGFA
SCHEMBL9543721 0.70 DRD4 (0.59) DRD2DRD4
SCHEMBL659637 0.70 PARP1 (0.46) PARP1CHRM2CHRM4CHRM1CHRM3
SCHEMBL9933964 0.69 CHRM2 (0.43) PARP1CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051415-B1 BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-09-24 EP disclosed
US-6495542-B1 SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-17 US disclosed